Tumor-associated glycoproteinMUC1 (mucin 1, cell surface associated) is a target for cancer immunotherapy.It is overexpressed by cancer cells, and the glycosylated proteinscan concentrate growth factors near cancer cell receptors, and theextensively glycosylated proteins can also block immune cells andtherapeutic drugs. This evidence concerns the gene MUC1 and cancer.